405 related articles for article (PubMed ID: 16428034)
1. Epidemiology and molecular biology of Barrett esophagus.
Casson AG; Williams L; Guernsey DL
Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
[TBL] [Abstract][Full Text] [Related]
2. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.
Williams LJ; Guernsey DL; Casson AG
Curr Oncol; 2006 Feb; 13(1):33-43. PubMed ID: 17576439
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: can biomarkers predict progression to malignancy?
Tischoff I; Tannapfel A
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):653-63. PubMed ID: 19072343
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
8. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
9. Management of Barrett's esophagus with dysplasia.
Hagen JA
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):285-9. PubMed ID: 9263347
[TBL] [Abstract][Full Text] [Related]
10. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
11. Dysplasia arising in barrett's esophagus: diagnostic pitfalls and natural history.
Goldblum JR; Lauwers GY
Semin Diagn Pathol; 2002 Feb; 19(1):12-9. PubMed ID: 11936261
[TBL] [Abstract][Full Text] [Related]
12. Multistage carcinogenesis in Barrett's esophagus.
Maley CC
Cancer Lett; 2007 Jan; 245(1-2):22-32. PubMed ID: 16713672
[TBL] [Abstract][Full Text] [Related]
13. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
Chang JT; Katzka DA
Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of p53 in Barrett's esophagus.
Keswani RN; Noffsinger A; Waxman I; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1243-9. PubMed ID: 16835318
[TBL] [Abstract][Full Text] [Related]
16. A clinical and histopathologic focus on Barrett esophagus and Barrett-related dysplasia.
Voltaggio L; Montgomery EA; Lam-Himlin D
Arch Pathol Lab Med; 2011 Oct; 135(10):1249-60. PubMed ID: 21970480
[TBL] [Abstract][Full Text] [Related]
17. [Barrett esophagus and Barrett carcinoma].
Kruyt PH; van Sandick JW; van Lanschot JJ; Offerhaus GJ; Tytgat GN; Obertop H
Ned Tijdschr Geneeskd; 1997 May; 141(18):869-73. PubMed ID: 9273450
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for esophageal cancer development.
Falk GW
Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
[TBL] [Abstract][Full Text] [Related]
19. [Gastroesophageal reflux disease and malignancy].
Richert Z; Robaszkiewicz M
Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):745-52. PubMed ID: 12163328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]